NASHVILLE, Tenn. – August Bioservices, in conjunction with the State of Tennessee’s Department of Economic and Community…
With tensions running high amid COVID-19 and a trade war with China, the “onshoring” movement for drug production…
“The pressure’s on,” former U.S. Sen. Majority Leader Bill Frist told Jenn Adams as he said goodbye to her on Nov. 18…
NASHVILLE, Tenn. – Tennessee Gov. Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe…
A Nashville-based biotechnology company will expand its local facility and create at least 180 new jobs over the next…
The goal of pharmaceutical development is to deliver novel therapies that can significantly improve the lives…
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.
To add large-scale lyophilization and sterile fill-finish capabilities to its clinical and commercial manufacturing offering.









